A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Trial Investigating the Efficacy and Safety of Clobetasol Propionate Cream, 0.025% in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days

Main Article Content

Seemal Desai
Zoe Draelos
Steve Feldman
J. Mark Jackson

Keywords

phase 3 study, psoriasis, clobetasol cream

Abstract

N/A

References

1. Draelos, Z. D., Fowler, J. F., & Cornelison, R. (2018). A Randomized, Parallel Group, Open Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with Clobetasol Propionate Cream (Impoyz™), 0.025% versus Clobetasol Propionate (Temovate®). SKIN The Journal of Cutaneous Medicine, 2(6). https://doi.org/10.25251/skin.2.6.16

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

<< < 1 2 3 > >>